Losing weight during COVID-19 pandemic is urgent as obesity increases risk of severe disease and death NORTHWESTERN UNIVERSITY CHICAGO — Losing weight during the COVID-19 pandemic has increasing urgency because obesity increases the risk of severe disease and death. Two-thirds of U.S. adults are overweight or obese, according to the Centers for Disease Control and...
Tag: <span>COVID-19</span>
Post
Physicians give first comprehensive review of COVID-19’s effects outside the lung
by Columbia University Irving Medical Center After only a few days caring for critically ill COVID-19 patients at the start of the outbreak in New York City, Aakriti Gupta, MD, realized that this was much more than a respiratory disease. “I was on the front lines right from the beginning. I observed that patients were...
Post
1 in 3 young adults may face severe COVID-19, UCSF study shows
Smoking habits trump asthma, obesity in risk factors for otherwise healthy population UNIVERSITY OF CALIFORNIA – SAN FRANCISCO As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children’s Hospitals indicates that youth may not shield people from serious disease. The study looked...
Post
FOR EACH COVID-19 DEATH, 9 FAMILY MEMBERS GRIEVE
Every death from COVID-19 will affect approximately nine surviving family members, according to a new study of kinship networks in the United States. Deaths from COVID-19 will have a ripple effect causing impacts on the mental health and health of surviving family members. But the extent of that impact has been hard to assess until...
Post
India clears a psoriasis drug for COVID-19, and a tiny US biotech’s shares soar
Dive Brief: India’s drug regulator has granted an emergency approval to the antibody drug itolizumab to treat the potentially deadly immune response, cytokine release syndrome, that appears to affect some patients hospitalized with acute respiratory distress related to COVID-19. The Drugs Controller General of India cleared the treatment for use after itolizumab, alongside standard of...
Post
Researchers discover first-in-class broad-inhibitor of paramyxovirus polymerases
by Georgia State University A new antiviral drug that is effective against a broad range of human pathogens in the paramyxovirus family, such as the human parainfluenzaviruses and measles virus, has been discovered by researchers in the Institute for Biomedical Sciences at Georgia State University. The drug binds to and inhibits paramyxovirus polymerases, the unique...
Post
Coronavirus research updates: Massive contact-tracing effort finds hundreds of cases linked to nightclubs
Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear. 10 July — Massive contact-tracing effort finds hundreds of cases linked to nightclubs Mobile phone and credit card data helped to identify nearly 250 coronavirus infections linked to a fast-moving outbreak that began in a popular nightclub district...
Post
Women taking beta blockers for hypertension may have higher risk of heart failure with acute coronary syndrome
DALLAS, July 13, 2020 — Women taking beta blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospital with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal. Beta blockers are...
Post
Liposuction treatment hope for coronavirus: Stem cells taken from fat-reduction donors boosts survival rates FIVE-fold for critically-ill patients hooked up to ventilators
Of a small number of patients, 15% died compared with the 85% expected Overall 70% of patients who were on the brink of death saw improvements The researchers admitted they did not expect such positive results The treatment works by injecting patients with cells taken from fat tissue The stem cells are known to bolster...
Post
COVID-19 DRUG MAY CUT DEATH RISK BY 45% FOR SEVERE CASES
In a new study, patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off a ventilator within a month, despite double the risk of additional infection. Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45%...